Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 42
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Y-DNA A00 and the Peoples of Cameroon: In Search of the Homeland

    This was the first phase of our fundraising campaign to support our fieldwork in Cameroon. We were very successful...

    How do chimpanzees adapt to a savanna woodland in Tanzania?

    75% of Tanzania’s chimpanzees live in open “savanna” woodlands. Considered a marginal habitat due to low food...

    Backer Badge Funded